NCT01491100View on ClinicalTrials.gov

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

1,085

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 22, 2016

Study Completion Date

April 5, 2017

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Patients treated with regular dose subcutaneously administered, according to the label and to clinical routine practice.

Trial Locations (17)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY